-
sodium (3R,5S)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate hydrate
-
ChemBase ID:
155064
-
Molecular Formular:
C24H27FNNaO5
-
Molecular Mass:
451.4630532
-
Monoisotopic Mass:
451.17709547
-
SMILES and InChIs
SMILES:
CC(C)n1c2ccccc2c(c1/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)c1ccc(cc1)F.O.[Na+]
Canonical SMILES:
[O-]C(=O)C[C@@H](C[C@@H](/C=C/c1c(c2ccc(cc2)F)c2c(n1C(C)C)cccc2)O)O.O.[Na+]
InChI:
InChI=1S/C24H26FNO4.Na.H2O/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30;;/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30);;1H2/q;+1;/p-1/t18-,19-;;/m1../s1
InChIKey:
KKEMYLLTGGQWCE-BAMQSBMESA-M
-
Cite this record
CBID:155064 http://www.chembase.cn/molecule-155064.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
sodium (3R,5S)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate hydrate
|
|
|
|
|
IUPAC Traditional name
|
|
sodium (3R,5S)-7-[3-(4-fluorophenyl)-1-isopropylindol-2-yl]-3,5-dihydroxyhept-6-enoate hydrate
|
|
|
|
|
Synonyms
|
|
(±)-(3R*,5S*,6E)-7-[3-(4-Fluorophenyl)-1-(1-methyethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid sodium salt hydrate
|
|
Fluvastatin sodium hydrate
|
|
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
4.55701
|
H Acceptors
|
4
|
H Donor
|
2
|
LogD (pH = 5.5)
|
2.837187
|
LogD (pH = 7.4)
|
1.0636245
|
Log P
|
3.8259492
|
Molar Refractivity
|
125.6924 cm3
|
Polarizability
|
45.93319 Å3
|
Polar Surface Area
|
85.52 Å2
|
Rotatable Bonds
|
8
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
SML0038
|
Biochem/physiol Actions Fluvastatin is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Fluvastatin is antilipemic and is used to reduce plasma cholesterol levels and prevent cardiovascular disease. |
PATENTS
PATENTS
PubChem Patent
Google Patent